Global Edition news

By Dave Muoio July 14, 2020
This morning continuous glucose monitor (CGM) startup Movano Inc. exited stealth with the news of $10 million bridge funding round headed by Tri-Valley Ventures. Taken alongside its prior investments, the company said it has now raised $27 million since its founding in 2018. WHAT THEY DO Movano is developing a connected CGM wearable that doesn't require the user to break the skin with a needle or...
By Mallory Hackett July 13, 2020
Paige, a computational pathology platform, announced today an additional $15 million from Goldman Sachs Merchant Banking Division, bringing the total capital from the firm to $20 million.  Healthcare Venture Partners also contributed an additional $5 million on top of its previous $10 million investment. With this funding, the previously announced Series B financing round increased to $70 million...
By Laura Lovett July 13, 2020
Swedish pharma company Orexo is jumping into the American digital-therapeutics game with the announcement of two new products, deprexis for treating depression symptoms and vorvida, a treatment for problematic alcohol use.  The new treatments are coming to the US market thanks to relaxed FDA regulations surrounding digital health products for psychiatric disorders, which was enacted as a result...
By Dave Muoio July 13, 2020
UnitedHealth Group announced plans this morning to distribute a device-driven diabetes management model to 230,000 employer-sponsored members with Type 2 diabetes at no additional cost. The pilot program, called Level2 by UnitedHealthcare, provides members with a Dexcom G6 continuous glucose monitor (CGM) that connects to their smartphone, a Fitbit activity tracker, personalized coaching and...
By Laura Lovett July 13, 2020
VR for pain. A new study published by JMIR found that virtual reality was a feasible and scalable means of treating chronic pain. The study, which used AppliedVR’s technology, split participants into two groups: a VR cohort and an audio one.  Participants in the VR group were mailed a headset, with accompanying software, speakers and microphone. Participants in this group were asked to complete...
By Dave Muoio July 10, 2020
The World Health Organization has announced a new smoking cessation initiative that will combine free nicotine replacement therapies with an artificial intelligence-based "virtual health worker." The digital tool comes from virtual-avatar-maker Soul Machines, and aims to dispel misinformation about COVID-19 and tobacco use while helping develop personalized plans to quit smoking. Florence, as she...
By Jonah Comstock July 10, 2020
Economic downturns and catastrophic events can often prompt market consolidation, so perhaps it's no great surprise that the first half of 2020 has been unusually active when it comes to mergers and acquisitions, especially in the second quarter. MobiHealthNews tracked 23 confirmed acquisitions in Q2, plus one credibly reported one, and another 11 in Q1, for 35 so far this year – six up from last...
By Stephanie Nieman July 10, 2020
About the author: Stephanie Nieman is a principal at SJF Ventures based in Durham, N.C. SJF Ventures is a venture capital fund investing in high-growth, positive-impact companies across the U.S. and an active healthcare investor. The current COVID-19 pandemic and resulting need for schools and universities to close, and for families to socially distance and practice remote learning, have only...
By Dave Muoio July 9, 2020
Satisfaction with COVID-19 screening chatbots and adherence to the information they provide is primarily driven by the user's perception of the tool's ability, according to research recently published in the Journal of the American Medical Informatics Association. Conducted by researchers from Indiana University and Temple University's respective business schools, the investigation asked...
By Mallory Hackett July 9, 2020
AliveCor released today KardiaCare, a digital subscription service for managing heart health at home. The service offers a suite of features that helps users interpret their heart data, monitor risk factors, identify symptom triggers and measure the impact of lifestyle changes. It will expand upon the features already provided with the company’s other ECG products, KardiaMobile and KardiaMobile...